Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research & Pathophysiology II (PD49)1 Sep 2021PD49-08 CORRELATING IMMUNE CELL INFILTRATION PATTERNS WITH RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA Nicholas Chakiryan, Ali Hajiran, Youngchul Kim, Jad Chahoud, Philippe Spiess, Liang Wang, Carlos Moran-Segura, Jonathan Nguyen, Jasreman Dhillon, James Mule, and Brandon Manley Nicholas ChakiryanNicholas Chakiryan More articles by this author , Ali HajiranAli Hajiran More articles by this author , Youngchul KimYoungchul Kim More articles by this author , Jad ChahoudJad Chahoud More articles by this author , Philippe SpiessPhilippe Spiess More articles by this author , Liang WangLiang Wang More articles by this author , Carlos Moran-SeguraCarlos Moran-Segura More articles by this author , Jonathan NguyenJonathan Nguyen More articles by this author , Jasreman DhillonJasreman Dhillon More articles by this author , James MuleJames Mule More articles by this author , and Brandon ManleyBrandon Manley More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002071.08AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Clear cell renal cell carcinoma (ccRCC) tumors harbor comparatively low frequencies of genetic alterations yet very high levels of immune cell infiltration. Identifying associations between specific ccRCC somatic mutations and patterns of immune cell infiltration within the tumor immune microenvironment could be impactful in both research and clinical settings. METHODS: Pre-treatment tumor specimens were collected from 48 patients with metastatic ccRCC. Next-generation sequencing was performed using a 275-gene comprehensive cancer panel. Formalin-fixed paraffin-embedded tissue samples were then stained using 2 multiplex immunofluorescence (IF) panels to identify T cells (CD3, CD8, FOXP3, TBet) and myeloid cells (CD68, CD163, CD206). Using digital image analysis, immune cell marker densities were analyzed in 3 regions of interest (ROIs): the tumor core, the tumor-stroma interface, and the surrounding stroma. Using TCGA, CPTAC, and Moffitt TCC genomic data sources, enrichment scores for individual cell lines were determined from the sequencing panels using the xCell bioinformatic pipeline and compared with IF infiltration patterns. A linear mixed model analysis was performed to test associations between IF patterns and genetic alterations. Log-rank and multivariable Cox regression were used to analyze survival outcomes. RESULTS: Tissue from 24 primary tumors and 24 metastatic tumors were analyzed. The most frequent somatic mutations included VHL (79.1%), BAP1 (41.7%), SETD2 (41.7%), PBRM1 (35.4%), TP53 (18.8%), and KDM5C (16.7%). Overall, tumors with SETD2 mutations had significantly decreased levels of FOXP3+ T regulatory cells across all 3 ROIs. PBMR1 mutations were associated with decreased tumor core FOXP3+ T regulatory cells. KDM5C mutations were associated with significantly increased macrophage tumor infiltration (CD206+ and CD68+/206+). BAP1 mutated tumors had increased sequencing-derived macrophage enrichment scores in TCGA and CPTAC, and AVATAR, but without an associated increase in IF-detected macrophage infiltration in primary tumor samples for any ROI. On multivariable analysis, patients with SETD2 mutations had significantly worse overall survival (p <0.01) and survival following immunotherapy treatment (p <0.01). Patients with KDM5C had worse overall survival (p=0.02) and survival following immunotherapy (p=0.048). CONCLUSIONS: This study provides evidence that there are associations between somatic mutations, such as SETD2 and KDM5C, and macrophage and T cell infiltration patterns in the TIME in ccRCC. Sequencing-derived xCell enrichment scores from TCGA, CPTAC, and AVATAR were discordant with the IF-derived immune cell infiltration findings. These novel associations have the potential to inform precision research and immunotherapeutic treatment strategies. Source of Funding: N/A © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e847-e848 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Nicholas Chakiryan More articles by this author Ali Hajiran More articles by this author Youngchul Kim More articles by this author Jad Chahoud More articles by this author Philippe Spiess More articles by this author Liang Wang More articles by this author Carlos Moran-Segura More articles by this author Jonathan Nguyen More articles by this author Jasreman Dhillon More articles by this author James Mule More articles by this author Brandon Manley More articles by this author Expand All Advertisement Loading ...

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Comprehensive proteogenomic characterization of rare kidney tumors

Comprehensive Genomic Profiling in Chinese Patients with Clear Cell Renal Cell Carcinoma.

Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma

Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma

Correlating Immune Cell Infiltration Patterns with Recurrent Somatic Mutations in Advanced Clear Cell Renal Cell Carcinoma

PD49-08 CORRELATING IMMUNE CELL INFILTRATION PATTERNS WITH RECURRENT SOMATIC MUTATIONS IN CLEAR CELL RENAL CELL CARCINOMA

Chromatin Accessibility Shapes Tumor Architecture and Microenvironment in Clear Cell Renal Cell Carcinoma

Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets

Single-nucleus sequencing unveils heterogeneity in renal cell carcinomas microenvironment: Insights into pathogenic origins and treatment-responsive cellular subgroups

Abstract 1846: Integrative histopathologic, proteomic, phosphoproteomic, genomic, and transcriptomic characterization of renal cell carcinoma

Transcriptome- and proteome-wide association studies identify genes associated with renal cell carcinoma

Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma

A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population.

A Proteogenomic Atlas of Clear Cell Renal Cell Carcinoma in a Chinese Population

A proteogenomic portrait of lung squamous cell carcinoma

Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression

The integrate profiling of single-cell and spatial transcriptome RNA-seq reveals tumor heterogeneity, therapeutic targets, and prognostic subtypes in ccRCC